The latest earnings season for America's biggest companies is shaping up to be a blockbuster, with profits surging compared with a year ago. But beneath the headline numbers, one major sector has turned from a tailwind into a drag: healthcare.
With about 89% of S&P 500 companies having reported results, Oppenheimer Asset Management estimates that year-over-year earnings growth stands at roughly 51%. That's a slight pullback from the 57% growth rate estimated a week earlier, but still a remarkably strong showing for corporate America.
Energy and tech lead the charge
The gains have been led by two sectors that have been on very different trajectories. Energy companies have seen profits soar by an estimated 147% year-over-year, a surge driven largely by higher oil and gas prices over the past year. Technology has also been a major contributor, with strong demand for software, cloud services, and artificial intelligence-related products boosting bottom lines.
Oppenheimer noted that every other sector in the index also posted profit growth, which is a sign that the earnings recovery is broad-based rather than concentrated in just a few names.
Healthcare's sudden reversal
The one standout exception is healthcare. According to Oppenheimer, the sector swung to a 7.5% decline in earnings compared with a year ago. That's a sharp reversal from just a week earlier, when healthcare was showing a 20% gain.
The shift is notable because healthcare is one of the largest sectors in the S&P 500, so its performance has an outsized impact on the index's overall earnings. A swing of that magnitude can shave several percentage points off the aggregate growth rate.
What's behind the decline? The brief doesn't specify, but healthcare companies have faced a mix of challenges this year, including rising costs, pricing pressures, and a tough comparison against a strong year-ago period. Some drugmakers have also seen sales of COVID-related products fade, while others have dealt with patent expirations or clinical trial setbacks. For example, recent news in the sector has been mixed, with some positive developments offset by disappointments.
What this means for investors
For everyday investors, the key takeaway is that corporate earnings remain healthy, which is generally supportive for stock prices. A 51% year-over-year jump in profits is well above the historical average, and it reflects an economy that, while slowing, is still growing.
However, the healthcare drag is a reminder that not all sectors move in the same direction. Even in a strong earnings season, individual industries can face headwinds. Investors with heavy exposure to healthcare stocks may want to pay attention to why the sector is underperforming and whether the decline is a temporary blip or a longer-term trend.
It's also worth noting that the earnings growth rate has ticked down from 57% to 51% as more companies have reported. That's normal as the season progresses, but it does suggest that the final numbers may come in slightly below the early estimates.
Looking ahead, investors will be watching to see if the healthcare weakness spreads or remains contained. They'll also be keeping an eye on whether energy and tech can sustain their momentum. As earnings season shines, but AI expectations keep rising, the market's focus may shift to forward guidance rather than just past results.
For those who own broad index funds, the strong earnings picture is a positive sign. But it's always wise to remember that past performance doesn't guarantee future results, and sector-specific surprises can create volatility.
In the coming weeks, as the final batch of companies reports, we'll get a clearer picture of whether the 51% growth rate holds or gets revised further. Either way, this earnings season is proving to be one of the strongest in recent memory, even with healthcare's stumble.
